ERYTHROPOIETIC PROTOPORPHYRIA
Clinical trials for ERYTHROPOIETIC PROTOPORPHYRIA explained in plain language.
Never miss a new study
Get alerted when new ERYTHROPOIETIC PROTOPORPHYRIA trials appear
Sign up with your email to follow new studies for ERYTHROPOIETIC PROTOPORPHYRIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial offers hope for people who Can't go in the sun
Disease control CompletedThis study tested whether an oral drug called bitopertin could help adults with erythropoietic protoporphyria (EPP), a condition that causes severe pain from sunlight exposure. Seventy-five participants were randomly assigned to receive either bitopertin or a placebo pill for abo…
Matched conditions: ERYTHROPOIETIC PROTOPORPHYRIA
Phase: PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Apr 04, 2026 04:50 UTC
-
Common heartburn drug tested as potential lifeline for rare, painful sunlight disorder
Disease control CompletedThis study tested whether cimetidine, a common heartburn medication, could help people with rare genetic disorders (EPP and XLP) that cause severe, painful reactions to sunlight. In this Phase 2 trial, 26 participants took either cimetidine or a placebo for three months to see if…
Matched conditions: ERYTHROPOIETIC PROTOPORPHYRIA
Phase: PHASE2 • Sponsor: Amy K. Dickey, M.D. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Drug tested for rare sunlight allergy
Disease control CompletedThis study aimed to understand how the drug afamelanotide is processed by the body in people with erythropoietic protoporphyria (EPP), a rare condition causing severe pain from sunlight. It involved 28 adolescent and adult patients. Researchers measured the drug's levels in the b…
Matched conditions: ERYTHROPOIETIC PROTOPORPHYRIA
Phase: PHASE1, PHASE2 • Sponsor: Clinuvel Europe Limited • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC